✦ LIBER ✦

The development of angioedema in a patient with type 2 diabetes due to a novel dipeptidyl peptidase-IV inhibitor, anagliptin

✍ Scribed by Hamasaki, Hidetaka; Yanai, Hidekatsu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibitors of dipeptidyl peptidase IV: a

✍ Deacon, Carolyn F; Ahrén, Bo; Holst, Jens J 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 209 KB

A triumph for physiology driving drug di

✍ Richard Donnelly 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Contributing factors related to efficacy

✍ Takashi Nomiyama; Yuko Akehi; Hiromasa Takenoshita; Ryoko Nagaishi; Yuichi Teraw 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Hormonal and metabolic effects of mornin

✍ Yan-Ling He; Jessica Valencia; Yiming Zhang; Sherwyn L. Schwartz; Monica Liguero 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 974 KB

Linagliptin , a dipeptidyl peptidase-4 i

✍ Forst, Thomas; Pfützner, Andreas 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 257 KB

Effect of sitagliptin, a dipeptidyl pept

✍ L. Xu; C. Dalla Man; B. Charbonnel; G. Meninger; M. J. Davies; D. Williams-Herma 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB